UK markets open in 31 minutes

Avadel Pharmaceuticals plc (AVDL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
18.18-0.44 (-2.36%)
At close: 04:00PM EDT
19.00 +0.82 (+4.51%)
After hours: 06:54PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 3.40B
Enterprise value 3.29B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)52.15
Price/book (mrq)19.94
Enterprise value/revenue 117.78
Enterprise value/EBITDA -22.09

Trading information

Stock price history

Beta (5Y monthly) 1.63
52-week change 317.29%
S&P500 52-week change 325.38%
52-week high 319.09
52-week low 39.50
50-day moving average 316.63
200-day moving average 313.76

Share statistics

Avg vol (3-month) 31.21M
Avg vol (10-day) 3797.28k
Shares outstanding 596.12M
Implied shares outstanding 6186.69M
Float 889.84M
% held by insiders 14.62%
% held by institutions 158.49%
Shares short (15 Apr 2024) 410.61M
Short ratio (15 Apr 2024) 414.32
Short % of float (15 Apr 2024) 412.60%
Short % of shares outstanding (15 Apr 2024) 411.04%
Shares short (prior month 15 Mar 2024) 410.47M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-128.00%

Management effectiveness

Return on assets (ttm)-57.92%
Return on equity (ttm)-481.35%

Income statement

Revenue (ttm)27.96M
Revenue per share (ttm)0.35
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -136.08M
Net income avi to common (ttm)-160.28M
Diluted EPS (ttm)-2.00
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)105.11M
Total cash per share (mrq)1.16
Total debt (mrq)35.38M
Total debt/equity (mrq)40.33%
Current ratio (mrq)3.64
Book value per share (mrq)0.98

Cash flow statement

Operating cash flow (ttm)-128.51M
Levered free cash flow (ttm)-77.95M